FDA 483 - Felling, Bruce & Kelly - August 03, 2023

An FDA inspection of Felling, Bruce & Kelly, a grower in Belgrade, MN, revealed two significant observations related to animal drug use. The firm failed to review treatment records to ensure appropriate drug withdrawal periods were met before an animal was offered for slaughter. Additionally, extralabel drug use resulted in drug residues above established safe levels in an animal offered for sale.